SiPhox was founded in 2020, to develop a next-generation biosensing platform that provides the power a large laboratory instruments in a handheld device that accepts disposable cartridges. SiPhox’s interdisciplinary team merges biochemistry and photonic chip technology to deliver more biomarker data, faster, and with less blood volume.

Silicon photonics enabled the massive scaling of datacenters and fiber communication to support internet connectivity. Siphox leveraged the same core technology to miniaturize a complex optical system used in central labs for blood testing. This enables lab-quality results in a consumer form factor.